Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kolodziej

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 27, 2020
Pumps and The New PillsEmma J Birks, Andrew Kolodziej
Obesity (Silver Spring, Md.)|June 18, 2024
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profileYuval Cohen, Andrew Kolodziej, Marshall Morningstar
Heart Rhythm O2|September 12, 2024
Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapyAaron B Hesselson, Gaurang Vaidya, Andrew Kolodziej
Heartrhythm Case Reports|March 2, 2023
Super-response to cardiac resynchronization therapy in orthotopic heart transplant with atypical right bundle branch block and cardiac allograft vasculopathyJad A Ballout, Karam Ayoub, Andrew Kolodziej, et al.
Journal of Cardiology|July 11, 2024
Using electronic medical records to identify patients at risk for underlying cardiac amyloidosisMichael A Pascoe, Andrew Kolodziej, Emma J Birks, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 2, 2019
Airway Management and Positive Pressure Ventilation in Severe Right Ventricular Failure: SAVIOR AlgorithmHabib Srour, Joe Shy, Zach Klinger, et al.
BMJ Case Reports|July 1, 2025
Combined cellular and antibody-mediated rejection of orthotopic heart transplant following influenza A infectionJoseph Crowder, Jeffrey F Spindel, Nathan Shelman, et al.
Obesity (Silver Spring, Md.)|October 16, 2023
Novel cannabinoid receptor 1 inverse agonist CRB-913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet-induced obesity mouse modelMarshall Morningstar, Andrew Kolodziej, Suzie Ferreira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 AgonistRachel Luba, Gabriela Madera, Rebecca Schusterman, et al.
Clinical Transplantation|January 22, 2023
Patterns and outcomes of COVID-19 donor utilization for heart transplantGaurang Nandkishor Vaidya, Paul Anaya, Maya Ignaszewski, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 27, 2020
Pumps and The New PillsEmma J Birks, Andrew Kolodziej
Obesity (Silver Spring, Md.)|June 18, 2024
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profileYuval Cohen, Andrew Kolodziej, Marshall Morningstar
Heart Rhythm O2|September 12, 2024
Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapyAaron B Hesselson, Gaurang Vaidya, Andrew Kolodziej
Heartrhythm Case Reports|March 2, 2023
Super-response to cardiac resynchronization therapy in orthotopic heart transplant with atypical right bundle branch block and cardiac allograft vasculopathyJad A Ballout, Karam Ayoub, Andrew Kolodziej, et al.
Journal of Cardiology|July 11, 2024
Using electronic medical records to identify patients at risk for underlying cardiac amyloidosisMichael A Pascoe, Andrew Kolodziej, Emma J Birks, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 2, 2019
Airway Management and Positive Pressure Ventilation in Severe Right Ventricular Failure: SAVIOR AlgorithmHabib Srour, Joe Shy, Zach Klinger, et al.
BMJ Case Reports|July 1, 2025
Combined cellular and antibody-mediated rejection of orthotopic heart transplant following influenza A infectionJoseph Crowder, Jeffrey F Spindel, Nathan Shelman, et al.
Obesity (Silver Spring, Md.)|October 16, 2023
Novel cannabinoid receptor 1 inverse agonist CRB-913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet-induced obesity mouse modelMarshall Morningstar, Andrew Kolodziej, Suzie Ferreira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 AgonistRachel Luba, Gabriela Madera, Rebecca Schusterman, et al.
Clinical Transplantation|January 22, 2023
Patterns and outcomes of COVID-19 donor utilization for heart transplantGaurang Nandkishor Vaidya, Paul Anaya, Maya Ignaszewski, et al.
Pageof 2